End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET

• Karan L. Chohan,
• Jason R. Young,
• Scott Lester,
• Muhamad Alhaj Moustafa,
• Allison Rosenthal,
• Han W. Tun,
• Bradford S. Hoppe,
• Patrick B. Johnston,
• Ivana N. Micallef,
• Thomas M. Habermann,
• Stephen M. Ansell

Affiliations

Karan L. Chohan

Department of Medicine, Mayo Clinic, Rochester, MN

Jason R. Young

Department of Radiology, Mayo Clinic, Jacksonville, FL

Scott Lester

Department of Radiation Oncology, Mayo Clinic, Rochester, MN

Muhamad Alhaj Moustafa

Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Allison Rosenthal

Division of Hematology, Mayo Clinic, Phoenix, AZ

Han W. Tun

Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Bradford S. Hoppe

Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL

Patrick B. Johnston

Division of Hematology, Mayo Clinic, Rochester, MN

Ivana N. Micallef

Division of Hematology, Mayo Clinic, Rochester, MN

Thomas M. Habermann

Division of Hematology, Mayo Clinic, Rochester, MN

Stephen M. Ansell

Division of Hematology, Mayo Clinic, Rochester, MN